Use of WEB 2086 and WEB 2170 As Platelet-activating Factor Antagonists
Overview
Authors
Affiliations
Impact of targeting the platelet-activating factor and its receptor in cancer treatment.
Qaderi K, Shahmoradi A, Thyagarajan A, Sahu R Mil Med Res. 2025; 12(1):10.
PMID: 40033370 PMC: 11877967. DOI: 10.1186/s40779-025-00597-0.
Chaiyabutr N, Chanhome L, Vasaruchapong T, Laoungbua P, Khow O, Rungsipipat A Toxicon X. 2020; 7:100046.
PMID: 32875291 PMC: 7452022. DOI: 10.1016/j.toxcx.2020.100046.
Lordan R, Tsoupras A, Zabetakis I, Demopoulos C Molecules. 2019; 24(23).
PMID: 31816871 PMC: 6930554. DOI: 10.3390/molecules24234414.
Papakonstantinou V, Lagopati N, Tsilibary E, Demopoulos C, Philippopoulos A Bioinorg Chem Appl. 2017; 2017:6947034.
PMID: 28458618 PMC: 5387815. DOI: 10.1155/2017/6947034.
LysoPC and PAF Trigger Arachidonic Acid Release by Divergent Signaling Mechanisms in Monocytes.
Oestvang J, Anthonsen M, Johansen B J Lipids. 2011; 2011:532145.
PMID: 21912747 PMC: 3170782. DOI: 10.1155/2011/532145.